|SEQ_NO||1||Date of announcement||2021/10/13||Time of announcement||16:51:02|
|Subject||Announcement of TTY Biopharm's unaudited income information in September 2021|
|Date of events||2021/10/13||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2021/10/13
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $389,573 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $123,806 thousands, and a consolidated income before tax of $147,535 thousands in September 2021; net income attributed to stockholders of the parent company was $122,896 thousands; EPS is $0.49.
Year-to-date consolidated net sales was $3,067,163 thousands (in NT dollars; unaudited), a consolidated operating profit was $763,880 thousands and consolidated income before tax was $663,181 thousands until September 2021; year-to-date net income attributed to stockholders of the company was $489,744 thousands; EPS is $1.97.
7.Any other matters that need to be specified:
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.